Company: JUNS
Filing Date: 2025-11-26
Form Type: S-1
Source: 0001493152-25-025204
Chunk: 214

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-26
Form: S-1
Chunk 214
---
 are authorized for issuance:

| Plan category                                              |     | Number of securities to be issued upon exercise of outstanding options, warrants and rights |            |     | Weighted-average exercise price of outstanding options, warrants and rights ($) |      |     | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) |           |
|                                                            |     | -a                                                                                          |            |     | -b                                                                              |      |     | -c                                                                                                                                          |           |
| Equity compensation plans approved by security holders     |     |                                                                                             |  8,311,224 |     |                                                                                 | 0.94 |     |                                                                                                                                             | 5,849,061 |
| Equity compensation plans not approved by security holders |     |                                                                                             |  5,308,303 |     |                                                                                 | 1.20 |     |                                                                                                                                             |         0 |
| Total                                                      |     |                                                                                             | 13,619,527 |     |                                                                                 | 1.04 |     |                                                                                                                                             | 5,849,061 |

The Company’s stockholders
approved the 2016 Equity Incentive Plan (“2016 Plan”) on January 4, 2016. Under the 2016 Plan, as modified, 8,437,500 shares
of common stock are authorized for issuance to employees, officers, directors, consultants. The 2016 Plan authorizes the grant of nonqualified
stock options and incentive stock options, restricted stock awards, restricted stock units, stock appreciation rights, under the 2016
Plan. The Company does not intend to make any additional grants under the 2016 Plan.

| 122 |

The Board and stockholders
of the Company approved the 2021 Equity Incentive Plan (the “2021 Plan”) on September 17, 2021. Under the 2021 Plan, 1,125,000
shares of common stock were initially authorized for issuance to employees, directors and independent contractors (except those performing
services in connection with the offer or sale of the Company’s securities in a capital raising transaction, or promoting or maintaining
a market for the Company’s securities) of the Company or its subsidiaries. The 2021 Plan authorizes equity-based and cash-based
incentives for participants. On July 22, 2022, the Board increased the shares authorized for issuance pursuant to the 2021 Plan to 1,710,000.
The Company